Nifty
Sensex
:
:
12858.40
43828.10
-196.75 (-1.51%)
-694.92 (-1.56%)

Pesticides & Agrochemicals

Rating :
68/99

BSE: 533138 | NSE: ASTEC

953.25
24-Nov-2020
  • Open
  • High
  • Low
  • Previous Close
  •  943.00
  •  968.30
  •  933.00
  •  937.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  147084
  •  1401.05
  •  1367.00
  •  310.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,865.82
  • 24.11
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,963.04
  • 0.16%
  • 6.71

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.96%
  • 2.78%
  • 22.44%
  • FII
  • DII
  • Others
  • 0.56%
  • 0.26%
  • 4.00%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.92
  • 16.17
  • 12.45

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.47
  • 21.97
  • 4.37

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 25.56
  • 57.07
  • 10.82

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 24.23
  • 28.88
  • 30.32

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.32
  • 6.21
  • 5.92

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.38
  • 18.23
  • 15.54

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
155.00
140.22
10.54%
111.94
76.99
45.40%
180.57
133.76
35.00%
124.83
119.43
4.52%
Expenses
125.50
124.95
0.44%
83.66
70.60
18.50%
137.88
110.67
24.59%
104.00
98.20
5.91%
EBITDA
29.50
15.27
93.19%
28.28
6.38
343.26%
42.69
23.09
84.89%
20.84
21.23
-1.84%
EBIDTM
19.04%
10.89%
25.26%
8.29%
14.01%
14.01%
16.69%
17.77%
Other Income
1.85
1.82
1.65%
1.25
0.94
32.98%
5.24
5.76
-9.03%
3.93
3.07
28.01%
Interest
1.13
3.58
-68.44%
1.53
3.49
-56.16%
2.15
3.15
-31.75%
3.38
3.61
-6.37%
Depreciation
6.34
5.68
11.62%
6.26
5.56
12.59%
6.15
5.48
12.23%
5.78
5.36
7.84%
PBT
23.88
7.83
204.98%
21.74
-1.72
-
39.63
20.22
95.99%
15.61
15.33
1.83%
Tax
6.03
2.54
137.40%
5.55
-0.61
-
8.45
7.49
12.82%
3.44
5.35
-35.70%
PAT
17.86
5.29
237.62%
16.18
-1.11
-
31.18
12.73
144.93%
12.17
9.98
21.94%
PATM
11.52%
3.77%
14.46%
-1.44%
7.11%
7.11%
9.75%
8.36%
EPS
9.11
2.70
237.41%
8.26
-0.57
-
15.91
6.49
145.15%
6.21
5.09
22.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
572.34
522.61
430.90
367.58
298.67
246.99
266.88
206.97
174.77
112.84
109.44
Net Sales Growth
21.67%
21.28%
17.23%
23.07%
20.92%
-7.45%
28.95%
18.42%
54.88%
3.11%
 
Cost Of Goods Sold
4,886.00
338.53
279.49
235.05
179.94
160.93
178.74
133.37
118.05
77.67
81.40
Gross Profit
-4,313.66
184.07
151.41
132.54
118.74
86.05
88.14
73.60
56.72
35.17
28.05
GP Margin
-753.69%
35.22%
35.14%
36.06%
39.76%
34.84%
33.03%
35.56%
32.45%
31.17%
25.63%
Total Expenditure
451.04
437.43
354.43
298.79
236.27
215.43
212.77
171.60
147.77
97.35
93.80
Power & Fuel Cost
-
28.80
23.80
17.87
15.75
13.84
3.56
6.90
9.15
5.46
2.77
% Of Sales
-
5.51%
5.52%
4.86%
5.27%
5.60%
1.33%
3.33%
5.24%
4.84%
2.53%
Employee Cost
-
29.92
25.10
21.71
20.38
15.89
12.27
11.38
8.73
5.58
4.02
% Of Sales
-
5.73%
5.83%
5.91%
6.82%
6.43%
4.60%
5.50%
5.00%
4.95%
3.67%
Manufacturing Exp.
-
10.16
8.67
7.41
6.67
4.71
0.89
5.61
0.47
0.31
1.12
% Of Sales
-
1.94%
2.01%
2.02%
2.23%
1.91%
0.33%
2.71%
0.27%
0.27%
1.02%
General & Admin Exp.
-
11.27
7.87
8.92
7.86
9.60
9.03
6.55
4.91
3.18
1.81
% Of Sales
-
2.16%
1.83%
2.43%
2.63%
3.89%
3.38%
3.16%
2.81%
2.82%
1.65%
Selling & Distn. Exp.
-
5.58
3.87
5.40
2.91
3.97
5.37
5.32
5.00
2.06
1.92
% Of Sales
-
1.07%
0.90%
1.47%
0.97%
1.61%
2.01%
2.57%
2.86%
1.83%
1.75%
Miscellaneous Exp.
-
13.17
5.63
2.43
2.77
6.49
2.90
2.47
1.46
3.08
1.92
% Of Sales
-
2.52%
1.31%
0.66%
0.93%
2.63%
1.09%
1.19%
0.84%
2.73%
0.70%
EBITDA
121.31
85.18
76.47
68.79
62.40
31.56
54.11
35.37
27.00
15.49
15.64
EBITDA Margin
21.20%
16.30%
17.75%
18.71%
20.89%
12.78%
20.28%
17.09%
15.45%
13.73%
14.29%
Other Income
12.27
11.93
11.16
8.11
2.86
7.21
0.93
0.37
1.06
0.61
1.21
Interest
8.19
12.59
12.38
10.66
12.24
12.81
12.84
9.25
7.48
5.66
4.06
Depreciation
24.53
23.16
19.35
14.68
13.68
10.40
12.69
14.77
11.87
8.64
5.83
PBT
100.86
61.35
55.90
51.56
39.34
15.57
29.52
11.72
8.71
1.81
6.96
Tax
23.47
13.83
20.14
20.67
9.56
7.36
-2.20
2.50
2.81
0.54
2.09
Tax Rate
23.27%
22.54%
36.03%
37.10%
33.26%
59.26%
-17.49%
22.42%
32.26%
29.83%
30.03%
PAT
77.39
47.51
35.74
34.91
19.12
4.97
14.77
8.67
5.95
1.36
4.88
PAT before Minority Interest
77.38
47.53
35.77
35.04
19.18
5.07
14.78
8.65
5.90
1.27
4.88
Minority Interest
-0.01
-0.02
-0.03
-0.13
-0.06
-0.10
-0.01
0.02
0.05
0.09
0.00
PAT Margin
13.52%
9.09%
8.29%
9.50%
6.40%
2.01%
5.53%
4.19%
3.40%
1.21%
4.46%
PAT Growth
187.80%
32.93%
2.38%
82.58%
284.71%
-66.35%
70.36%
45.71%
337.50%
-72.13%
 
EPS
39.48
24.24
18.23
17.81
9.76
2.54
7.54
4.42
3.04
0.69
2.49

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
246.57
202.49
169.65
138.02
118.03
135.34
113.49
105.75
98.53
96.80
Share Capital
19.57
19.55
19.53
19.51
19.46
19.46
18.53
18.04
16.93
16.93
Total Reserves
226.33
182.16
149.23
117.78
97.83
115.88
94.96
87.29
80.24
79.87
Non-Current Liabilities
6.46
9.48
4.86
1.70
6.47
48.94
53.76
52.89
36.26
46.01
Secured Loans
0.00
0.00
0.25
0.40
8.18
12.72
17.64
21.46
11.08
41.19
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.50
0.50
0.00
0.71
2.38
Long Term Provisions
0.32
0.23
0.17
0.07
0.45
0.74
0.73
1.19
0.34
0.00
Current Liabilities
318.36
248.80
238.39
193.72
202.97
177.58
117.17
102.31
96.47
36.13
Trade Payables
202.39
63.25
99.93
57.07
68.00
87.84
45.65
46.09
30.98
22.86
Other Current Liabilities
16.72
9.52
13.84
10.16
25.04
7.64
10.28
6.29
5.27
6.14
Short Term Borrowings
98.71
175.67
124.17
126.00
108.57
77.38
57.27
47.15
59.15
0.00
Short Term Provisions
0.54
0.36
0.44
0.50
1.37
4.72
3.96
2.79
1.07
7.13
Total Liabilities
571.72
461.08
413.18
333.59
327.56
361.91
284.46
261.08
231.44
179.17
Net Block
193.62
166.95
115.07
102.94
94.67
133.06
132.23
120.73
76.24
72.51
Gross Block
270.99
221.36
150.15
124.45
105.04
201.03
187.64
160.92
105.03
92.37
Accumulated Depreciation
77.36
54.41
35.08
21.51
10.37
67.96
55.40
40.20
28.79
19.86
Non Current Assets
239.97
212.60
181.50
135.22
136.37
158.40
149.57
142.51
123.12
89.51
Capital Work in Progress
24.11
18.98
41.87
7.56
19.85
12.25
5.84
13.07
43.62
8.99
Non Current Investment
0.01
0.01
0.01
0.01
0.01
0.02
0.01
0.08
0.01
8.01
Long Term Loans & Adv.
22.23
26.67
24.56
21.56
18.05
13.06
11.48
8.64
3.25
0.00
Other Non Current Assets
0.00
0.00
0.00
3.16
3.80
0.00
0.00
0.00
0.00
0.00
Current Assets
331.75
248.48
231.68
198.37
191.19
203.51
134.90
118.57
108.32
89.60
Current Investments
0.00
0.00
0.00
0.00
0.00
0.09
0.05
0.02
11.81
0.00
Inventories
121.17
92.85
78.48
65.55
71.25
71.93
76.59
50.66
50.38
36.85
Sundry Debtors
160.84
121.81
123.15
110.66
80.61
103.63
51.39
62.65
31.87
34.26
Cash & Bank
1.49
1.48
1.50
4.23
6.05
12.02
4.47
5.14
4.11
3.06
Other Current Assets
48.25
2.27
1.28
0.61
33.27
15.84
2.39
0.09
10.14
15.43
Short Term Loans & Adv.
41.82
30.07
27.28
17.32
31.05
15.30
2.39
0.09
10.14
15.43
Net Current Assets
13.39
-0.33
-6.71
4.65
-11.79
25.93
17.73
16.25
11.84
53.47
Total Assets
571.72
461.08
413.18
333.59
327.56
361.91
284.47
261.08
231.44
179.16

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
168.44
15.29
64.67
19.23
-12.53
7.48
14.58
16.43
8.65
16.39
PBT
61.35
55.90
55.71
28.74
12.42
18.98
8.65
5.90
1.37
4.88
Adjustment
37.48
30.35
17.94
34.84
18.77
23.30
24.87
20.12
14.70
10.44
Changes in Working Capital
87.83
-54.54
6.37
-37.69
-38.75
-32.19
-17.02
-8.09
-6.38
4.16
Cash after chg. in Working capital
186.66
31.71
80.02
25.89
-7.55
10.08
16.50
17.94
9.68
19.48
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-18.22
-16.42
-15.35
-6.66
-4.98
-2.60
-1.92
-1.50
-1.04
-3.09
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-73.81
-52.50
-48.94
-17.70
-16.05
-19.22
-18.69
-13.33
-50.01
-16.83
Net Fixed Assets
-55.18
-48.32
-60.02
-7.11
79.50
-15.46
-17.12
-25.75
-46.69
-35.76
Net Investments
0.00
0.00
0.00
0.00
0.60
-0.04
-0.03
11.71
-3.88
17.26
Others
-18.63
-4.18
11.08
-10.59
-96.15
-3.72
-1.54
0.71
0.56
1.67
Cash from Financing Activity
-94.53
37.09
-18.25
-0.94
30.68
11.66
3.44
-2.07
42.41
1.65
Net Cash Inflow / Outflow
0.10
-0.12
-2.51
0.60
2.09
-0.08
-0.67
1.04
1.05
1.21
Opening Cash & Equivalents
0.21
0.33
2.84
2.25
0.68
0.78
5.14
4.11
3.06
1.85
Closing Cash & Equivalent
0.31
0.21
0.33
2.84
2.25
0.70
4.47
5.14
4.11
3.06

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
125.66
103.16
86.42
70.36
60.28
69.56
61.25
58.38
57.40
57.14
ROA
9.20%
8.18%
9.38%
5.80%
1.47%
4.57%
3.17%
2.40%
0.62%
2.93%
ROE
21.24%
19.31%
22.90%
15.07%
4.01%
11.88%
7.91%
5.83%
1.31%
5.15%
ROCE
20.44%
20.31%
23.75%
16.08%
10.65%
11.96%
10.88%
9.28%
4.81%
8.17%
Fixed Asset Turnover
2.12
2.32
2.70
2.73
1.61
1.46
1.26
1.46
1.21
1.51
Receivable days
98.71
103.75
115.06
111.38
136.14
99.91
94.59
88.78
101.10
107.04
Inventory Days
74.74
72.56
70.88
79.66
105.79
95.72
105.53
94.90
133.36
112.65
Payable days
112.38
80.55
94.02
100.09
137.14
112.44
87.72
93.42
92.01
70.96
Cash Conversion Cycle
61.06
95.76
91.92
90.96
104.80
83.18
112.40
90.26
142.45
148.73
Total Debt/Equity
0.40
0.87
0.74
0.92
1.08
0.69
0.73
0.69
0.74
0.45
Interest Cover
5.87
5.52
6.23
3.35
1.97
1.98
2.21
2.16
1.32
2.72

News Update:


  • Astec Lifesciences sells entire equity stake in Astec Europe Sprl
    1st Sep 2020, 10:50 AM

    Accordingly, Astec Europe Sprl ceases to be a subsidiary of the Company

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.